1 |
CCL2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, NOD-like receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Yersinia infection, Chagas disease, Malaria, Human cytomegalovirus infection, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Rheumatoid arthritis, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
2 |
CD80
💬
| 11件: Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept
Abatacept
💬
|
Abatacept
| 27件: 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
3 |
CD86
💬
| 13件: Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Kaposi sarcoma-associated herpesvirus infection, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept
Abatacept
💬
|
Abatacept
| 27件: 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
4 |
CHRNA1
💬
| 2件: Virion - Ebolavirus, Lyssavirus and Morbillivirus Virion - Ebolavirus, Lyssavirus and Morbillivirus, Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
5 |
CHRNA1
💬
| 2件: Virion - Ebolavirus, Lyssavirus and Morbillivirus Virion - Ebolavirus, Lyssavirus and Morbillivirus, Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
6 |
CHRNA10
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
7 |
CHRNA10
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
8 |
CHRNA2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
9 |
CHRNA2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
10 |
CHRNA3
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
11 |
CHRNA3
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
12 |
CHRNA4
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
13 |
CHRNA4
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
14 |
CHRNA5
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
15 |
CHRNA5
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
16 |
CHRNA6
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
17 |
CHRNA6
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
18 |
CHRNA7
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
19 |
CHRNA7
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
20 |
CHRNA9
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
21 |
CHRNA9
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
22 |
CHRNB1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
23 |
CHRNB1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
24 |
CHRNB2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
25 |
CHRNB2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
26 |
CHRNB3
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
27 |
CHRNB3
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
28 |
CHRNB4
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
29 |
CHRNB4
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
30 |
CHRND
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
31 |
CHRND
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
32 |
CHRNE
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
33 |
CHRNE
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
34 |
CHRNG
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine bitartrate
Nicotine bitartrate
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
35 |
CHRNG
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬
|
36 |
DHFR
💬
| 3件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Folate transport and metabolism | Methotrexate sodium
Methotrexate sodium
💬
|
Methotrexate
| 39件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
37 |
DHFR
💬
| 3件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Folate transport and metabolism | Methotrexate
Methotrexate
💬
|
Methotrexate
| 39件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
38 |
DHFR
💬
| 3件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Folate transport and metabolism | Methotrexate sodium
Methotrexate sodium
💬
|
Methotrexate
| 39件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
39 |
DHFR
💬
| 3件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Folate transport and metabolism | Methotrexate
Methotrexate
💬
|
Methotrexate
| 39件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
40 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
41 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Ambrisentan
Ambrisentan
💬
|
Ambrisentan
| 8件: 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
42 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
43 |
EDNRB
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
44 |
EDNRB
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
45 |
FGFR1
💬
| 16件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
46 |
FGFR1
💬
| 16件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
47 |
FGFR2
💬
| 12件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
48 |
FGFR2
💬
| 12件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
49 |
FGFR3
💬
| 12件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
50 |
FGFR3
💬
| 12件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
51 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
52 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
53 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
54 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
55 |
GLP1R
💬
| 4件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Insulin secretion | Semaglutide
Semaglutide
💬
|
Semaglutide
| 4件: 6 6, 51, 84, 299 💬
|
56 |
GUCY1A
💬
| 10件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion | Riociguat
Riociguat
💬
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 💬
|
57 |
GUCY1A
💬
| 10件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion | Riociguat
Riociguat
💬
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 💬
|
58 |
GUCY1B
💬
| 10件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion | Riociguat
Riociguat
💬
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 💬
|
59 |
HARS
💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis | Efzofitimod
Efzofitimod
💬
|
Efzofitimod
| 2件: 51 51, 84 💬
|
60 |
HARS
💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis | Efzofitimod
Efzofitimod
💬
|
Efzofitimod
| 2件: 51 51, 84 💬
|
61 |
HMGCR
💬
| 3件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, AMPK signaling pathway, Bile secretion | Atorvastatin calcium
Atorvastatin calcium
💬
|
Atorvastatin
| 20件: 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
|
62 |
HMGCR
💬
| 3件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, AMPK signaling pathway, Bile secretion | Atorvastatin
Atorvastatin
💬
|
Atorvastatin
| 20件: 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
|
63 |
IL10
💬
| 23件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, FoxO signaling pathway, Efferocytosis, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pertussis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Staphylococcus aureus infection, Tuberculosis, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Systemic lupus erythematosus, Allograft rejection | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
64 |
IL12A
💬
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 17件: 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
65 |
IL12B
💬
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Proteoglycans in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 17件: 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
66 |
IL1A
💬
| 21件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Necroptosis, Cellular senescence, Osteoclast differentiation, Hematopoietic cell lineage, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Leishmaniasis, Tuberculosis, Measles, Influenza A, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Fluid shear stress and atherosclerosis | Rilonacept
Rilonacept
💬
|
Rilonacept
| 5件: 51 51, 84, 106, 107, 266 💬
|
67 |
IL1A
💬
| 21件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Necroptosis, Cellular senescence, Osteoclast differentiation, Hematopoietic cell lineage, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Leishmaniasis, Tuberculosis, Measles, Influenza A, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
68 |
IL1B
💬
| 43件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Human cytomegalovirus infection, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Rilonacept
Rilonacept
💬
|
Rilonacept
| 5件: 51 51, 84, 106, 107, 266 💬
|
69 |
IL1B
💬
| 43件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Human cytomegalovirus infection, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
70 |
IL1B
💬
| 43件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Human cytomegalovirus infection, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Canakinumab
Canakinumab
💬
|
Canakinumab
| 11件: 46 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
71 |
IL1R1
💬
| 13件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Th17 cell differentiation, Inflammatory mediator regulation of TRP channels, Pathogenic Escherichia coli infection, Shigellosis, Amoebiasis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Fluid shear stress and atherosclerosis | Anakinra
Anakinra
💬
|
Anakinra
| 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
|
72 |
IL1R2
💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Amoebiasis, Human T-cell leukemia virus 1 infection, Transcriptional misregulation in cancer, Prostate cancer, Fluid shear stress and atherosclerosis | Anakinra
Anakinra
💬
|
Anakinra
| 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
|
73 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 17件: 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
74 |
IL6
💬
| 49件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, Cellular senescence, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Transcriptional misregulation in cancer, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Hypertrophic cardiomyopathy, Lipid and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
75 |
IL6R
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th17 cell differentiation, Non-alcoholic fatty liver disease, Human cytomegalovirus infection, Coronavirus disease - COVID-19, Pathways in cancer | Sarilumab
Sarilumab
💬
|
Sarilumab
| 5件: 41 41, 46, 84, 107, 271 💬
|
76 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
77 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate sodium
Mycophenolate sodium
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
78 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
79 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate sodium
Mycophenolate sodium
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
80 |
JAK1
💬
| 27件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Baricitinib
Baricitinib
💬
|
Baricitinib
| 21件: 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
81 |
JAK1
💬
| 27件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
82 |
JAK1
💬
| 27件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Tofacitinib citrate
Tofacitinib citrate
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
83 |
JAK1
💬
| 27件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Abrocitinib
Abrocitinib
💬
|
Abrocitinib
| 2件: 39 39, 84 💬
|
84 |
JAK2
💬
| 25件: Chemokine signaling pathway Chemokine signaling pathway, Hormone signaling, Efferocytosis, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Baricitinib
Baricitinib
💬
|
Baricitinib
| 21件: 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
85 |
JAK2
💬
| 25件: Chemokine signaling pathway Chemokine signaling pathway, Hormone signaling, Efferocytosis, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tofacitinib citrate
Tofacitinib citrate
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
86 |
JAK2
💬
| 25件: Chemokine signaling pathway Chemokine signaling pathway, Hormone signaling, Efferocytosis, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
87 |
JAK3
💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Hepatitis B, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Non-small cell lung cancer, Primary immunodeficiency | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
88 |
JAK3
💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Hepatitis B, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Non-small cell lung cancer, Primary immunodeficiency | Tofacitinib citrate
Tofacitinib citrate
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
89 |
KDR
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer, Fluid shear stress and atherosclerosis | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
90 |
KDR
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer, Fluid shear stress and atherosclerosis | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
91 |
MC2R
💬
| 6件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome | Corticotropin
Corticotropin
💬
|
Corticotropin
| 11件: 13 13, 46, 50, 66, 75, 78, 81, 84, 145, 205, 222 💬
|
92 |
MC2R
💬
| 6件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome | Corticotropin, repository
Corticotropin, repository
💬
|
Corticotropin
| 11件: 13 13, 46, 50, 66, 75, 78, 81, 84, 145, 205, 222 💬
|
93 |
MS4A1
💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab
Rituximab
💬
|
Rituximab
| 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
94 |
MTOR
💬
| 49件: ErbB signaling pathway ErbB signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, Autophagy - other, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Apelin signaling pathway, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Th17 cell differentiation, Thermogenesis, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Growth hormone synthesis, secretion and action, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Pancreatic cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Diabetic cardiomyopathy | Sirolimus
Sirolimus
💬
|
Sirolimus
| 46件: 2 2, 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
95 |
NR1H4
💬
| 1件: Bile secretion Bile secretion | Ursodiol
Ursodiol
💬
|
Ursodeoxycholic acid
| 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
|
96 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone
Prednisone
💬
|
Prednisone
| 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
97 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone
Dexamethasone
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
98 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
99 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Ciclesonide
Ciclesonide
💬
|
Ciclesonide
| 1件: 84 84 💬
|
100 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone phosphate
Dexamethasone phosphate
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
101 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone
Prednisolone
💬
|
Prednisolone
| 41件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 61, 63, 64, 66, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
102 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone sodium phosphate
Dexamethasone sodium phosphate
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
103 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone acetate
Methylprednisolone acetate
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
104 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬
|
105 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬
|
106 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬
|
107 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬
|
108 |
PDE5
💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway | Tadalafil
Tadalafil
💬
|
Tadalafil
| 8件: 6 6, 51, 75, 77, 84, 86, 113, 210 💬
|
109 |
PDGFRA
💬
| 19件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Phospholipase D signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
110 |
PDGFRA
💬
| 19件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Phospholipase D signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
111 |
PDGFRB
💬
| 18件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer | Nintedanib esylate
Nintedanib esylate
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
112 |
PDGFRB
💬
| 18件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
113 |
PRKAA
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 28件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
114 |
PRKAA
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 28件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
115 |
PRKAA
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin hydrochloride
Metformin hydrochloride
💬
|
Metformin
| 28件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
116 |
PRKAA
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin hydrochloride
Metformin hydrochloride
💬
|
Metformin
| 28件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
117 |
PTGIR
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | Iloprost
Iloprost
💬
|
Iloprost
| 4件: 51 51, 84, 85, 86 💬
|
118 |
PTGIR
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | Selexipag
Selexipag
💬
|
Selexipag
| 6件: 47 47, 51, 70, 84, 86, 88 💬
|
119 |
PTGIR
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | Iloprost tromethamine
Iloprost tromethamine
💬
|
Iloprost
| 4件: 51 51, 84, 85, 86 💬
|
120 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin sodium
Heparin sodium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
121 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin calcium
Heparin calcium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
122 |
SLC5A1
💬
| 3件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Bile secretion, Mineral absorption | Sotagliflozin
Sotagliflozin
💬
|
Sotagliflozin
| 2件: 58 58, 84 💬
|
123 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Methylphenidate
Methylphenidate
💬
|
Methylphenidate
| 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
|
124 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Methylphenidate hydrochloride
Methylphenidate hydrochloride
💬
|
Methylphenidate
| 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
|
125 |
SLC6A3
💬
| 8件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism | Methylphenidate hydrochloride
Methylphenidate hydrochloride
💬
|
Methylphenidate
| 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
|
126 |
SLC6A3
💬
| 8件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism | Armodafinil
Armodafinil
💬
|
Armodafinil
| 3件: 6 6, 13, 84 💬
|
127 |
SLC6A3
💬
| 8件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism | Methylphenidate
Methylphenidate
💬
|
Methylphenidate
| 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
|
128 |
SSTR2
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Growth hormone synthesis, secretion and action, Gastric acid secretion | Octreotide pamoate
Octreotide pamoate
💬
|
Octreotide
| 8件: 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
129 |
SSTR2
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Growth hormone synthesis, secretion and action, Gastric acid secretion | Octreotide acetate
Octreotide acetate
💬
|
Octreotide
| 8件: 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
130 |
SSTR2
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Growth hormone synthesis, secretion and action, Gastric acid secretion | Octreotide acetate
Octreotide acetate
💬
|
Octreotide
| 8件: 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
131 |
SSTR2
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Growth hormone synthesis, secretion and action, Gastric acid secretion | Octreotide
Octreotide
💬
|
Octreotide
| 8件: 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
132 |
SSTR2
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Growth hormone synthesis, secretion and action, Gastric acid secretion | Edotreotide gallium Ga-68
Edotreotide gallium Ga-68
💬
|
Dotatate gallium Ga-68
| 4件: 19 19, 75, 84, 238 💬
|
133 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Golimumab
Golimumab
💬
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 💬
|
134 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
135 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Infliximab
Infliximab
💬
|
Infliximab
| 25件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
|
136 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Adalimumab
Adalimumab
💬
|
Adalimumab
| 21件: 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
137 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Thalidomide
Thalidomide
💬
|
Thalidomide
| 21件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
138 |
TYK2
💬
| 17件: Necroptosis Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Deucravacitinib
Deucravacitinib
💬
|
Deucravacitinib
| 9件: 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|
139 |
TYK2
💬
| 17件: Necroptosis Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Tofacitinib citrate
Tofacitinib citrate
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
140 |
TYK2
💬
| 17件: Necroptosis Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 22件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
141 |
VDR
💬
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | Cholecalciferol
Cholecalciferol
💬
|
Cholecalciferol
| 23件: 6 6, 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
|
142 |
VDR
💬
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | Ergocalciferol
Ergocalciferol
💬
|
Ergocalciferol
| 6件: 46 46, 49, 84, 96, 97, 299 💬
|